Comparison of computed tomography and magnetic resonance imaging in the evaluation of focal hepatic lesions
Jerome Barakos(Sutter Health), Thomas Gilbert(Imaging Center), Jeffrey J. Brown(The University of Texas MD Anderson Cancer Center), Henry I. Goldberg(University of California, San Francisco)
Cited by 27
Related Papers
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|741
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
|JAMA Neurology|2021|602
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
|The Lancet Neurology|2012|512
The Magnetic Resonance Imaging Appearance of Individual Structures of the Posterolateral Knee
|The American Journal of Sports Medicine|2000|299